OptimizeRx Corporation (NASDAQ: OPRX) is 26.48% higher on its value in year-to-date trading and has touched a low of $6.50 and a high of $17.24 in the current 52-week trading range. The OPRX stock was last observed hovering at around $13.03 in the last trading session, with the day’s loss setting it -0.04% off its average median price target of $22.00 for the next 12 months. It is also 56.7% off the consensus price target high of $30.00 offered by 4 analysts, but current levels are 23.59% higher than the price target low of $17.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $12.99, the stock is 1.03% and 14.14% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 75452.0 and changing -0.31% at the moment leaves the stock 19.87% off its SMA200. OPRX registered -19.17% loss for a year compared to 6-month gain of 26.48%. The firm has a 50-day simple moving average (SMA 50) of $12.12 and a 200-day simple moving average (SMA200) of $10.19.
The stock witnessed a 5.18% loss in the last 1 month and extending the period to 3 months gives it a 55.76%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.54% over the week and 6.55% over the month.
OptimizeRx Corporation (OPRX) has around 70 employees, a market worth around $187.71M and $27.00M in sales. Fwd P/E is 42.87. Profit margin for the company is -19.80%. Distance from 52-week low is 99.79% and -24.65% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.20%).
OptimizeRx Corporation (OPRX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for OptimizeRx Corporation (OPRX) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.80, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
OptimizeRx Corporation is expected to release its quarterly report on 08/11/2020 and quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $7.97M over the same period., but quarterly earnings will post 35.30% year-over-year.
OptimizeRx Corporation (OPRX) Top Institutional Holders
82 institutions hold shares in OptimizeRx Corporation (OPRX), with 2.72M shares held by insiders accounting for 18.55% while institutional investors hold 69.97% of the company’s shares. The shares outstanding are 14.61M, and float is at 11.91M with Short Float at 7.15%. Institutions hold 56.98% of the Float.
OptimizeRx Corporation (OPRX) Insider Activity
A total of 13 insider transactions have happened at OptimizeRx Corporation (OPRX) in the last six months, with sales accounting for 0 and purchases happening 13 times.